Delivery Order SPE2DB22D1106-SPE2DB24FELD7
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,537.14 firm fixed-price delivery order is for the provision of M-M-R II vaccine vials. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, that serves as the primary vehicle for the company to deliver...
- This federal contract award, valued at $5,160.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of M-M-R II vaccine vials and is a firm fixed-price delivery order without a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of M-M-R II vaccine vials and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $4,785.12 fixed-price contract is for the supply of M-M-R II vaccine vials, with a period of performance through May 8, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
- This federal contract award, valued at $2,271.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of M-M-R II vaccine vials. The contract, valued at $54,270.30, is a firm-fixed-price delivery order with a period of performance through June 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $27,694.50 for the supply of M-M-R II vaccine vials. The contract is issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,196.97 firm fixed price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance through May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a wide range of pharmaceutical products...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The $10,841.67 contract has an ultimate completion date of April 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is for the delivery of M-M-R II vaccine vials, with a ceiling value of $7,967.81 and a completion date of July 3, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FELD7Delivery Order
This federal contract award, valued at $5,123.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of M-M-R II vaccine vials and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This latest award is a firm fixed price delivery order issued under the IDC. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 4/12/24 |